{"cluster": 50, "subcluster": 46, "abstract_summ": "Coronavirus Disease 2019 (COVID\u201019) is mainly an acute respiratory infectious disease caused by a novel coronavirus (officially named Severe acute respiratory syndrome coronavirus 2, SARS\u2010CoV\u20102) in December 2019, which is currently a worldwide pandemic, mainly causes the novel coronavirus pneumonia (NCP).The spectrum of COVID-19 infection ranges from mild respiratory illness, to viral pneumonia and life-threatening acute respiratory distress syndrome in up 15-20% (Huang, et al 2020, Wu and McGoogan 2020).Health services across the world face an unprecedented situation as a result of a global COVID\u201019 outbreak.Faced with the new challenges in the pandemic control, imported COVID\u201019 infections and asymptomatic infection, Chinese authorities have implemented new intervention measures\u2010\u2010\u2010\u2010 national large\u2010scale nucleic acid testing.This article summarizes the population who needs the nucleic acid testing, analyzes the current data of daily COVID\u201019 tests per thousand people, concludes the timeline of coronavirus testing and suggests what needs to be done to facilitate the government large\u2010scale screening measures.Therefore, it is suggested to combine the two methods to improve the detection accuracy of COVID\u201019.Coronavirus disease 2019 (COVID\u201019), an infectious outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102),(1) has now progressed to global pandemic.(2) Besides the compelling need to understand the novel biological pathways underlying the virulence and pathogenicity of SARS\u2010CoV\u20102 in humans to enable the development of appropriate interventions and therapies,(3,4) the noticeable difference in mortality rates between Asian and European populations is one of the most significant issues demanding the attention of biologists, epidemiologists and clinicians around the world.", "title_summ": "Temporal changes in immune blood cell parameters in COVID\u201019 infection and recovery from severe infectionThe impact of coronavirus infectious disease 19 (COVID\u201019) on oral healthCOVID\u201019: Recommended sampling sites at different stage of the diseaseLarge\u2010scale National Screening for COVID\u201019 in ChinaInfluenza\u2010like illnesses caused by a cluster of imported Italian COVID\u201019Recent progress on the diagnosis of 2019 Novel CoronavirusClinical and demographic characteristics of patients dying from COVID\u201019 in Italy versus ChinaCase Report:The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current PandemicA case report of possible novel coronavirus 2019 reinfection", "title_abstract_phrases": "COVID\u201019: Recommended sampling sites at different stage of the diseaseCoronavirus Disease 2019 (COVID\u201019) is mainly an acute respiratory infectious disease caused by a novel coronavirus (officially named Severe acute respiratory syndrome coronavirus 2, SARS\u2010CoV\u20102) in December 2019, which is currently a worldwide pandemic, mainly causes the novel coronavirus pneumonia (NCP).The spectrum of COVID-19 infection ranges from mild respiratory illness, to viral pneumonia and life-threatening acute respiratory distress syndrome in up 15-20% (Huang, et al 2020, Wu and McGoogan 2020).The impact of coronavirus infectious disease 19 (COVID\u201019) on oral healthHealth services across the world face an unprecedented situation as a result of a global COVID\u201019 outbreak.Large\u2010scale National Screening for COVID\u201019 in ChinaFaced with the new challenges in the pandemic control, imported COVID\u201019 infections and asymptomatic infection, Chinese authorities have implemented new intervention measures\u2010\u2010\u2010\u2010 national large\u2010scale nucleic acid testing.The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current PandemicThe early shortage of novel coronavirus disease (COVID-19) tests in the United States led many hospitals to first screen for common respiratory pathogens, and only if this screen was negative to proceed with COVID-19 testing.Recent progress on the diagnosis of 2019 Novel CoronavirusCoronavirus disease 2019 (COVID\u201019) caused by severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) has become a global pandemic."}